NK has no conflicts of interest to declare
Yes, patients with type 2 diabetes require alternative pharmacotherapy to maintain glycemic targets after stopping semaglutide
For example, in a small randomized study, people with alcohol use disorder who received low-dose semaglutide not only drank less during a monitored lab session but reported fewer weekly alcohol cravings as well
It only offers compounded medications, which arent FDA approved and may not be available in all states
* When printed on SprintRay Pro with Ludicrous Speed profile
In a phase II study involving patients with mild AD (ELAD, NCT01843075), 12 months treatment with liraglutide failed to improve cerebral glucose uptake, but there were encouraging indicators with regard to cognitive function and grey matter volume [88]